Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis

Journal of Immunology

Volumn 177, Issue 9, 2006, Pages 6471-6479

  Devauchelle, Valérie ^a,b   Essabbani, Abdellatif ^a,c,d,e   De Pinieux, Gonzague ^f   Germain, Stéphane ^g,h   Tourneur, Léa ^a,c,d,e   Mistou, Sylvie ^a,c,d,e   Margottin Goguet, Florence ^a,c,d,e   Anract, Philippe ^f   Migaud, Henri ⁱ   Le Nen, Dominique ^b   Lequerré, Thierry ^c   Saraux, Alain ^b   Dougados, Maxime ^f   Breban, Maxime ^a,c,d,e,i,j   Fournier, Catherine ^a,c,d,e   Chiocchia, Gilles ^a,c,d,e,j,k  

^a INSTITUT COCHIN   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

^c INSERM   (France)

^d CNRS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f Hôpital Cochin ^*  (France)

^g l'alimentation et l'Environnement   (France)

^h HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

ⁱ LILLE UNIVERSITY HOSPITAL   (France)

^j HÔPITAL AMBROISE PARÉ   (France)

^k Pavillon Hardy A1   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; ISOPROTEIN; MESSENGER RNA; PROTEIN;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; WESTERN BLOTTING;

EID: 33750347516     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.9.6471     Document Type: Article

References (40)

1. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Rheumatoid arthritis. Cell 85: 307-310.
2. Fujinami, M., K. Sato, S. Kashiwazaki, and S. Aotsuka. 1997. Comparable histological appearance of synovitis in seropositive and seronegative rheumatoid arthritis. Clin. Exp. Rheumatol. 15: 11-17.
3. Devauchelle, V., S. Marion, N. Cagnard, S. Mistou, G. Falgarone, M. Breban, F. Letourneur, A. Pitaval, O. Alibert, C. Lucchesi, et al. 2004. DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets. Genes Immun. 5: 597-608.
4. French, L. E., A. Chonn, D. Ducrest, B. Baumann, D. Belin, A. Wohlwend, J. Z. Kiss, A. P. Sappino, J. Tschopp, and J. A. Schifferli. 1993. Murine clusterin: molecular cloning and mRNA localization of a gene associated with epithelial differentiation processes during embryogenesis. J. Cell Biol. 122: 1119-1130.
5. Aronow, B. J., S. D. Lund, T. L. Brown, J. A. Harmony, and D. P. Witte. 1993. Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc. Natl. Acad. Sci. USA 90: 725-729.
6. Jones, S. E., and C. Jomary. 2002. Clusterin. Int. J. Biochem. Cell Biol. 34: 427-424.
7. Murphy, B. F., L. Kirszbaum, I. D. Walker, and A. J. d'Apice. 1988. SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J. Clin. Invest. 81: 1858-1864.
8. Slawin, K., I. S. Sawczuk, C. A. Olsson, and R. Buttyan. 1990. Chromosomal assignment of the human homologue encoding SGP-2. Biochem. Biophys. Res. Commun. 172: 160-164.
9. Leskov, K. S., D. Y. Klokov, J. Li, T. J. Kinsella, and D. A. Boothman. 2003. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278: 11590-11600.
10. Yang, C. R., K. Leskov, K. Hosley-Eberlein, T. Criswell, J. J. Pink, T. J. Kinsella, and D. A. Boothman. 2000. Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. Proc. Natl. Acad. Sci. USA 97: 5907-5912.
11. Debure, L., J. L. Vayssiere, V. Rincheval, F. Loison, Y. Le Drean, and D. Michel. 2003. Intracellular clusterin causes justanuclear aggregate formation and mitochondrial alteration. J. Cell Sci. 116: 3109-3121.
12. Santilli, G., B. J. Aronow, and A. Sala. 2003. Essential requirement of apolipoprotein J (clusterin) signaling for IκB expression and regulation of NF-κB activity. J. Biol. Chem. 278: 38214-38219.
13. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
14. Le Jan, S., C. Amy, A. Cazes, C. Monnot, N. Lamande, J. Favier, J. Philippe, M. Sibony, J. M. Gase, P. Corvol, and S. Germain. 2003. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am. J. Pathol. 162: 1521-1528.
15. July, L. V., E. Beraldi, A. So, L. Fazli, K. Evans, J. C. English, and M. E. Cleave. 2004. Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo. Mol. Cancer Ther. 3: 223-232.
16. Trougakos, I. P., A. So, B. Jansen, M. E. Cleave, and E. S. Gonos. 2004. Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res. 64: 1834-1842.
17. Shibakawa, A., H. Aoki, K. Masuko-Hongo, T. Kato, M. Tanaka, K. Nishioka, and H. Nakamura. 2003. Presence of pannus-like tissue on osteoarthritic cartilage and its histological character. Osteoarthritis Cartilage 11: 133-140.
18. Hogasen, K., T. E. Mollnes, M. Harboe, O. Gotze, H. B. Hammer, and M. Oppermann. 1995. Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid. J. Rheumatol. 22: 24-28.
19. Trougakos, I., and E. Gonos. 2002. Clusterin/Apolipoprotein J in human aging and cancer. Int. J. Biochem. Cell Biol. 34: 1430.
20. Petropoulou, C., I. P. Trougakos, E. Kolettas, O. Toussaint, and E. S. Gonos. 2001. Clusterin/apolipoprotein J is a novel biomarker of cellular senescence that does not affect the proliferative capacity of human diploid fibroblasts. FEBS Lett. 509: 287-297.
21. Bettuzzi, S., F. Scorcioni, S. Astancolle, P. Davalli, M. Scaltriti, and A. Corti. 2002. Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression. Oncogene 21: 4328-4334.
22. Poon, S., T. M. Treweek, M. R. Wilson, S. B. Easterbrook-Smith, and J. A. Carver. 2002. Clusterin is an extracellular chaperone that specifically interacts with slowly aggregating proteins on their off-folding pathway. FEBS Lett. 513: 259-266.
23. Matsuda, A., Y. Itoh, N. Koshikawa, T. Akizawa, I. Yana, and M. Seiki. 2003. Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils. J. Biol. Chem. 278: 36350-36357.
24. Connor, J. R., S. Kumar, G. Sathe, J. Mooney, S. P. O'Brien, P. Mui, P. R. Murdock, M. Gowen, and M. W. Lark. 2001. Clusterin expression in adult human normal and osteoarthritic articular cartilage. Osteoarthritis Cartilage 9: 727-737.
25. Heller, R. A., M. Schena, A. Chai, D. Shalon, T. Bedilion, J. Gilmore, D. E. Woolley, and R. W. Davis. 1997. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc. Natl. Acad. Sci. USA 94: 2150-2155.
26. McLaughlin, L., G. Zhu, M. Mistry, C. Ley-Ebert, W. D. Stuart, C. J. Florio, P. A. Groen, S. A. Win, T. R. Kimball, D. P. Witte, et al. 2000. Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J. Clin. Invest. 106: 1105-1113.
27. Newkirk, M. M., P. Apostolakos, C. Neville, and P. R. Fortin. 1999. Systemic lupus erythematosus, a disease associated with low levels of clusterin/apoJ, an antiinflammatory protein. J. Rheumatol. 26: 597-603.
28. Lakins, J., S. A. Bennett, J. H. Chen, J. M. Arnold, C. Morrissey, P. Wong, J. O'Sullivan, and M. Tenniswood. 1998. Clusterin biogenesis is altered during apoptosis in the regressing rat ventral prostate. J. Biol. Chem. 273: 27887-27895.
29. Trougakos, I. P., M. Lourda, G. Agiostratidou, D. Kletsas, and E. S. Gonos. 2005. Differential effects of clusterin/apolipoprotein J on cellular growth and survival. Free Radic. Biol. Med. 38: 436-449.
30. Caccamo, A. E., M. Scaltriti, A. Caporali, D. D'Arca, F. Scorcioni, S. Astancolle, M. Mangiola, and S. Bettuzzi. 2004. Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin. Biochem. J. 382: 157-168.
31. 2-M phase arrest and cell death in PC-3 prostate cancer cells1. Cancer Res. 64: 6174-6182.
32. Barnes, P. J., and M. Karin. 1997. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071.
33. Bondeson, J., B. Foxwell, F. Brennan, and M. Feldmann. 1999. Defining therapeutic targets by using adenovirus: blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares antiinflammatory mediators. Proc. Natl. Acad. Sci. USA 96: 5668-5673.
34. Miagkov, A. V., D. V. Kovalenko, C. E. Brown, J. R. Didsbury, J. P. Cogswell, S. A. Stimpson, A. S. Baldwin, and S. S. Makarov. 1998. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl. Acad. Sci. USA 95: 13859-13864.
35. Makarov, S. S. 2001. NF-κB in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res. 3: 200-206.
36. Tak, P. P., D. M. Gerlag, K. R. Aupperle, D. A. van de Geest, M. Overbeek, B. L. Bennett, D. L. Boyle, A. M. Manning, and G. S. Firestein. 2001. Inhibitor of nuclear factor κB kinase β is a key regulator of synovial inflammation. Arthritis Rheum. 44: 1897-1907.
37. Tak, P. P., and G. S. Firestein. 2001. NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 107: 7-11.
38. Aupperle, K., B. Bennett, Z. Han, D. Boyle, A. Manning, and G. Firestein. 2001. NF-κB regulation by IκB kinase-2 in rheumatoid arthritis synoviocytes. J. Immunol. 166: 2705-2711.
39. Aupperle, K. R., Y. Yamanishi, B. L. Bennett, F. Mercurio, D. L. Boyle, and G. S. Firestein. 2001. Expression and regulation of inducible IκB kinase (IKK-i) in human fibroblast-like synoviocytes. Cell. Immunol. 214: 54-59.
40. Andreakos, E., C. Smith, S. Kiriakidis, C. Monaco, R. de Martin, F. M. Brennan, E. Paleolog, M. Feldmann, and B. M. Foxwell. 2003. Heterogeneous requirement of IκB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy. Arthritis Rheum. 48: 1901-1912.